Phil Cunningham
|
|
| Phil Cunningham |
Biology Professor Phil Cunningham developed technologies to allow rapid identification of any mutation that might produce an antibiotic-resistant bacterial strain. This technology has been licensed to a start-up company, RiboNovix.